Sequana Medical NV Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	7.31	3.81	2.58	18.87	9.6	11.02
Cash & Short-Term Investments	7.31	3.81	2.58	18.87	9.6	11.02
Cash Growth	76.11%	47.34%	-86.31%	96.61%	-12.85%	97.19%
Accounts Receivable	-	-	0.04	0.11	0.08	0.02
Other Receivables	0.31	0.3	0.31	0.29	0.3	0.31
Receivables	0.31	0.3	0.36	0.41	0.38	0.34
Inventory	2.45	2.05	2.3	2.62	2.14	1.47
Prepaid Expenses	0.51	0.26	1.06	1.19	0.77	0.62
Other Current Assets	-	0	0	-	0	0
Total Current Assets	10.58	6.42	6.3	23.09	12.89	13.44
Property, Plant & Equipment	1.87	1.77	2.32	2.07	1.27	0.7
Long-Term Investments	0.1	0.1	0.1	0.09	0.08	0.07
Other Long-Term Assets	1.76	1.65	1.39	0.78	0.46	-0
Total Assets	14.57	9.94	10.1	26.03	14.71	14.21
Accounts Payable	1.12	1.89	2.74	3.23	2.19	2.01
Accrued Expenses	2.07	2.47	3.37	3.51	2.52	1.3
Current Portion of Long-Term Debt	40.43	39.7	7.82	4.48	-	-
Current Portion of Leases	0.25	0.06	0.27	0.31	0.28	0.26
Current Unearned Revenue	-	-	0.17	0.16	0.17	0.79
Other Current Liabilities	8.28	9.1	5.1	3.45	2.01	1.6
Total Current Liabilities	52.16	53.21	19.47	15.15	7.18	5.97
Long-Term Debt	-	-	8.97	12.19	7.32	7.47
Long-Term Leases	0.73	0.36	0.46	0.61	0.48	0.12
Pension & Post-Retirement Benefits	0.86	0.75	0.67	0.23	0.51	0.54
Other Long-Term Liabilities	-	-	-	-	-	0
Total Liabilities	53.75	54.32	29.57	28.18	15.49	14.1
Common Stock	5.93	4.6	2.93	2.46	1.92	1.64
Additional Paid-In Capital	208.98	201.56	185.64	170.32	142.43	119.33
Retained Earnings	-268.95	-250.68	-206.02	-173.46	-142.7	-119.08
Comprehensive Income & Other	14.87	0.13	-2.01	-1.48	-2.45	-1.77
Shareholders' Equity	-39.17	-44.38	-19.47	-2.15	-0.79	0.11
Total Liabilities & Equity	14.57	9.94	10.1	26.03	14.71	14.21
Total Debt	41.4	40.11	17.52	17.59	8.09	7.86
Net Cash (Debt)	-34.09	-36.3	-14.94	1.28	1.52	3.16
Net Cash Growth	-	-	-	-15.34%	-52.00%	33.66%
Net Cash Per Share	-0.73	-0.99	-0.56	0.06	0.08	0.21
Filing Date Shares Outstanding	57.21	52.87	35.91	23.75	23.75	18.54
Total Common Shares Outstanding	57.21	44.44	28.24	23.75	18.58	15.78
Working Capital	-41.58	-46.79	-13.17	7.94	5.71	7.48
Book Value Per Share	-0.68	-1.00	-0.69	-0.09	-0.04	0.01
Tangible Book Value	-39.17	-44.38	-19.47	-2.15	-0.79	0.11
Tangible Book Value Per Share	-0.68	-1.00	-0.69	-0.09	-0.04	0.01
Machinery	-	1.69	1.69	1.52	0.9	0.67

Source: S&P Global Market Intelligence. Standard template. Financial Sources.